Kilitch Drugs(India) Share Price Today - Live Research Rating for Kilitch Drugs(India) on Equentis

Home

Stocks Screener

Kilitch Drugs(India) Share Price

Kilitch Drugs(India) (INR)32928.2 (9.4%)

Exchange ScripsBSE524500NSEKILITCHISININE729D01010

Stock Performance

Fundamentals

Technicals

Shareholding Patterns

Financials

Similar Stocks

Trendline of performance -

Kilitch Drugs(India) Performance

Market performance

Open price310

High358.4

Volumes286983

Prev Close329

Low310

Closing date2024-11-13

Historical performance

1 Year High470.00

3 Year High470.00

5 Year High470.00

1 Year Low300.00

3 Year Low125.00

5 Year Low61.00

Kilitch Drugs(India) Fundamentals

Company Valuation

Market Cap (₹Cr)

524

Face Value (₹)

P/E Ratio

36.24

Dividend Yield

N/A

Kilitch Drugs(India) Investment Returns

1 Year

1.6%

3 Years

90.8%

5 Years

149.1%

10 Years

1146.2%

Kilitch Drugs(India) Technicals

Indicators	Value	Signal
5-DMA	309.44	Bullish
10-DMA	312.87	Bullish
20-DMA	314.1	Bullish
50-DMA	338.14	Bearish
100-DMA	340.59	Bearish
200-DMA	354.4	Bearish

Shareholding Pattern

Field	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Promoters	4	3	3	3	3
Foreign Investors	---	---	---	---	---
Domestic Investors	4	3	3	3	3
Public Investors	9916	9617	9522	9059	8999
Government	---	---	---	---	---

Kilitch Drugs(India) Financials

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Other Income	45	29	29	27
Operating Profit	287	206	134	80
Interest	60	51	13	9
Depreciation	33	36	25	20
Profit Before Tax	194	120	96	51
Consolidated Net Profit	146	104	74	37
Adjusted EPS	9	7	5	2

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	161	156	156	155
Total Reserves	1599	1307	1206	1113
Minority Interest	-6	-10	12	24
Total Non-Current Liabilities	-24	-19	-12	-9
Total Liabilities	2375	2175	2083	2019
Capital Work in Progress	60	36	32	655
Total Assets	2375	2175	2083	2019

Cash Flow

Below figures are in Rs. Crores

Particulars	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Cash Flow from Operating Activities	-1	26	58	457
Cash Flow from Investing Activities	-95	79	-153	-376
Cash Flow from Financing Activitie	88	-7	70	16
Net Cash Inflow / Outflow	-9	98	-24	97

Negative

Neutral

Positive

The stock has a PE ratio of 36.24.
3Y Stock Price CAGR of the stock is 23.4.
The stock has a beta of 0.6.
In the last financial year, the company had an EBITDA of ₹287 Million.
The company generated revenue of ₹1544 Million in the previous financial year.

Kilitch Drugs(India)

32928.2 (9.4%)

Investment Amount: ₹ 32380

Current Value: ₹ 32900

Performence: 1.6%

P/L: ₹ 520

Top Gainers

Symbol	Change%
DEVIT	168.66(13%)
TERASOFT	155.15(10%)
AKASH	35.21(10%)
KILITCH	329(9%)
WINDMACHIN	273.19(8%)

Top Losers

Symbol	Change%
LOYALTEX	425.4(-20%)
KOPRAN	240.35(-18%)
PYRAMID	190.95(-16%)
WSI	112.07(-13%)
FAIRCHEMOR	876(-12%)
JITFINFRA	704.1(-11%)
SATIA	96.83(-11%)
SUMMITSEC	3163.7(-11%)

Similar stocks

Vimta Labs

▲ 36.2

759.95

October 13 - November 13

Innova Captab

▲ 34.5

961.1

October 13 - November 13

Unichem Lab

▲ 23.4

876.75

October 13 - November 13

Wockhardt

▲ 19.3

1189.4

October 13 - November 13

AMI Organics

▲ 18.7

1974.35

October 13 - November 13

Piramal Pharma

▲ 17.4

259.7

October 13 - November 13

Medico Remedies

▲ 17.1

56.2

October 13 - November 13

Hikal

▲ 13.9

387.2

October 13 - November 13

Announcing Stock of the Month!

Kilitch Drugs(India) Share PricePharmaceuticals & Drugs

Trendline of performance -

Kilitch Drugs(India) Performance

Market performance

Historical performance

Kilitch Drugs(India) Fundamentals

Company Valuation

Kilitch Drugs(India) Investment Returns

Kilitch Drugs(India) Technicals

Shareholding Pattern

Kilitch Drugs(India) Financials

Balance Sheet

Cash Flow

Top Gainers

Top Losers

Similar stocks

Kilitch Drugs(India) Share Price